Key result
A novel internal quality control test process for the PFA-100 demonstrated feasibility, yielding inter-run coefficients of variation of 3.1%-26.2% and stability over several years.
Population
Whole blood or cell-based testing systems, specifically the PFA-100 platelet function testing system
Design
Other
Authors
Loading...
May enable stable IQC for PFA-100 platelet testing; leaves open prospective validation before routine adoption.
A novel internal quality control process for the PFA-100 demonstrates feasibility and stability, offering a potential solution for IQC in whole blood and cell-based testing systems.
Emmanuel J. Favaloro (2012) studied Internal quality control for platelet function testing. Novel test process for IQC of the PFA-100 vs. Normal baseline CTs was evaluated on Inter-run test systems coefficients of variation (CVs). A novel internal quality control test process for the PFA-100 demonstrated feasibility, yielding inter-run coefficients of variation of 3.1%-26.2% and stability over several years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: